Mercado global de dispepsia funcional – Tendências do setor e previsão para 2028

Análise de Mercado e Insights: Mercado Global de Dispepsia Funcional

Espera-se que o mercado de dispepsia funcional ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 3,60% no período de previsão de pesquisa acima mencionado. Prevê-se que o crescente número de doentes que sofrem de dispepsia funcional aumente o crescimento adicional do mercado no período de previsão.

Além disso, a crescente consciencialização sobre a doença dispepsia funcional e a crescente preocupação com os seus sintomas previam impulsionar o ritmo de crescimento do mercado. Além disso, o diagnóstico precoce da Dispepsia Funcional oferece uma tremenda oportunidade para o crescimento do mercado. Mas, por vezes, prevê-se que efeitos adversos associados aos produtos de tratamento da Dispepsia Funcional, como cefaleias, diarreia, náuseas e vómitos, restrinjam o crescimento adicional do mercado. No entanto, as regulamentações rigorosas para a aprovação de medicamentos podem dificultar o desenvolvimento do mercado global de Dispepsia Funcional.

A dispepsia funcional refere-se ao reaparecimento de sintomas e sinais de indigestão sem motivo evidente específico. A dispepsia funcional é também conhecida como dispepsia não ulcerosa ou dor de estômago não ulcerosa. O consumo crescente de alimentos condimentados e oleosos induz dispepsia funcional e leva a aumentar a procura de produtos de tratamento para a dispepsia funcional. Consequentemente, antecipou acelerar o crescimento adicional do mercado.

This functional dyspepsia market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Functional Dyspepsia Market Scope and Market Size

Functional dyspepsia market is segmented on the basis of treatment, drugs type, diagnosis, symptoms, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the functional dyspepsia market is segmented into medications, and behaviour therapy.
• On the basis of drugs type, the functional dyspepsia market is segmented into h-2-receptor blockers, antacids, proton pump inhibitors, prokinetic agents, selective serotonin reuptake inhibitors (SSRIS), antibiotics and others.
• On the basis of diagnosis, the functional dyspepsia market is segmented into blood tests, breath tests, stool tests and others.
• On the basis of symptoms, the functional dyspepsia market is segmented into bloating, belching, nausea, burning and others.
• On the basis of end users, the functional dyspepsia market is segmented into hospitals, diagnostic centres, clinics and others.
• On the basis of distribution channel, the functional dyspepsia market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Functional Dyspepsia Market Country Level Analysis

Functional dyspepsia market is analysed and market size information is provided by country, treatment, drugs type, diagnosis, symptoms, end-users and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America accounts the largest market share due to the escalation in healthcare expenditure and presence of major key players. Europe accounts the second largest market share due to presence of advanced diagnosis technology and growing pace early diagnosis of functional dyspepsia. Asia-Pacific is expected to account for the largest market share over coming years for the functional dyspepsia market due to constant rise patient pool suffering from functional dyspepsia and rising per capita income leading to generate more demand for functional dyspepsia treatment products.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Functional dyspepsia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Functional Dyspepsia Market Share Analysis

Functional dyspepsia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to functional dyspepsia market.

The major players covered in the functional dyspepsia market are Bayer AG, Cadila Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., AstraZeneca plc., Jiangsu Aosaikang Pharmaceutical, Eisai Co., Ltd., Kyowa Kirin Pharmaceuticals, and Hanmi Pharmaceutical co., ltd., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Em maio de 2016, a IM HealthScience (IMH) anunciou a disponibilidade nacional do FDgard. O FDgard é um novo alimento médico especialmente formulado para a gestão dietética da Dispepsia Funcional, que tem sido caracterizada como indigestão persistente ou recorrente.

SKU-59384